Evidence map›Paper›PMID 31391509›Full record

ArticleScientific reports2019

Ensilication Improves the Thermal Stability of the Tuberculosis Antigen Ag85b and an Sbi-Ag85b Vaccine Conjugate.

A A Wahid, A Doekhie, A Sartbaeva, J M H van den Elsen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Thermal Stabilisation of Lysozyme through Ensilication.Molecules (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Review
  5. DeepTP: A Deep Learning Model for Thermophilic Protein Prediction.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Development of thermostable vaccine adjuvants.Expert review of vaccines · 2021
    Review
  10. Non-viral COVID-19 vaccine delivery systems.Advanced drug delivery reviews · 2021
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A A WahidDepartment of Biology and Biochemistry, University of Bath, Bath, UK.ORCID http://orcid.org/0000-0001-8128-9632
A DoekhieDepartment of Chemistry, University of Bath, Bath, UK.ORCID http://orcid.org/0000-0002-9612-7588
A SartbaevaDepartment of Chemistry, University of Bath, Bath, UK. A.Sartbaeva@bath.ac.uk.ORCID http://orcid.org/0000-0003-1017-0161
J M H van den ElsenDepartment of Biology and Biochemistry, University of Bath, Bath, UK. J.M.H.V.Elsen@bath.ac.uk.ORCID http://orcid.org/0000-0002-0367-1956
University of Bath · GB

Funding

Biotechnology and Biological Sciences Research Council BB/N022165/1
6 · The paper itself

Abstract

There is an urgent need for the development of vaccine thermostabilisation methodologies as the maintenance of a continuous and reliable cold chain remains a major hurdle to the global distribution of safe and effective vaccines. Ensilication, a method that encases proteins in a resistant silica cage has been shown to physically prevent the thermal denaturation of a number of model proteins. In this study we investigate the utility of this promising approach in improving the thermal stability of antigens and vaccine conjugates highly relevant to the development of candidate tuberculosis vaccines, including antigen 85b conjugated with the Staphylococcus aureus-protein based adjuvant Sbi. Here we analyse the sensitivity of these constructs to thermal denaturation and demonstrate for the first time the benefits of ensilication in conferring these vaccine-relevant proteins with protection against temperature-induced loss of structure and function without the need for refrigeration. Our results reveal the potential of ensilication in facilitating the storage and transport of vaccines at ambient temperatures in the future and therefore in delivering life-saving vaccines globally, and in particular to remote areas of developing countries where disease rates are often highest.

Indexed as

TemperatureAcyltransferasesAntigens, BacterialBacterial ProteinsCarrier ProteinsDrug StabilityEscherichia coliHumansProteolysisSerumSilicon DioxideTuberculosis VaccinesVaccines, ConjugateAcyltransferasesantigen 85B, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsCarrier ProteinsSbi protein, Staphylococcus aureusSilicon DioxideTuberculosis VaccinesVaccines, Conjugate

Identifiers

PMID31391509
PMCPMC6685958
OpenAlexW2964747197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.